Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: Nov 20, 2024, 4:00 PM
2.020
+0.010 (0.50%)
Pre-market: Nov 21, 2024, 7:10 AM EST

Cronos Group Revenue

Cronos Group had revenue of $34.26M in the quarter ending September 30, 2024, with 38.11% growth. This brings the company's revenue in the last twelve months to $111.23M, up 30.31% year-over-year. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.

Revenue (ttm)
$111.23M
Revenue Growth
+30.31%
P/S Ratio
n/a
Revenue / Employee
$312,441
Employees
356
Market Cap
761.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202387.24M492.00K0.57%
Dec 31, 202286.75M22.19M34.37%
Dec 31, 202164.56M17.84M38.19%
Dec 31, 202046.72M22.97M96.71%
Dec 31, 201923.75M11.63M95.94%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 694.96M
Avanos Medical 681.50M
Castle Biosciences 311.88M
Evolus 248.33M
Cytek Biosciences 201.21M
Avid Bioservices 142.36M
AbCellera Biologics 32.96M
Revenue Rankings